Prediction of severe lymphopenia during chemoradiotherapy for esophageal cancer

被引：0
|
作者：
Van Rossum, P. [1 ,2 ]
Deng, W. [2 ]
Routman, D. [3 ]
Liu, A. [4 ]
Xu, C. [2 ]
Shiraishi, Y. [2 ]
Peters, M. [1 ]
Merrell, K. [3 ]
Hallemeier, C. [3 ]
Mohan, R. [4 ]
Lin, S. [2 ]
机构：
[1] UMC Utrecht, Radiat Oncol, Utrecht, Netherlands
[2] Univ Texas MD Anderson Canc Ctr, Radiat Oncol, Houston, TX 77030 USA
[3] Mayo Clin, Radiat Oncol, Rochester, MN USA
[4] Univ Texas MD Anderson Canc Ctr, Radiat Phys, Houston, TX 77030 USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷
关键词：
D O I：
10.1016/S0167-8140(19)31215-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0795
引用
收藏
页码：S411 / S411
页数：1
相关论文
共 50 条
  • [21] Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes
    Xu, Hui
    Lin, Maosheng
    Hu, Yingying
    Zhang, Li
    Li, Qiaoqiao
    Zhu, Jinhan
    Wang, Shi
    Xi, Mian
    ONCOLOGIST, 2021, 26 (03): : E425 - E434
  • [22] Severe lymphopenia as a prognostic factor in rectal cancer patients receiving adjuvant chemoradiotherapy: a retrospective study
    Li, Shuang
    Yao, Weiping
    Liu, Ruiqi
    Lu, Yanwei
    Zhang, Haibo
    Liang, Xiaodong
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [23] Severe lymphopenia as a prognostic factor in rectal cancer patients receiving adjuvant chemoradiotherapy: a retrospective study
    Shuang Li
    Weiping Yao
    Ruiqi Liu
    Yanwei Lu
    Haibo Zhang
    Xiaodong Liang
    Scientific Reports, 13
  • [24] Predictors of Severe Lymphopenia During Chemoradiation Therapy for Anal Cancer
    Leonard, K. L.
    Breakstone, R.
    Wazer, D. E.
    Nack, E.
    Yu, E.
    Almhanna, K.
    Safran, H.
    Vrees, M.
    DiPetrillo, T. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E573 - E573
  • [25] The effect of spleen dose-volume parameters on lymphopenia during chemoradiotherapy for pancreatic cancer
    Inan, G. A.
    Aral, I. P.
    Ozturk, H. F.
    Gani, Z.
    Arslan, S. A.
    Tezcan, Y.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2023, 21 (03):
  • [26] Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer
    Atsumi, Kazushige
    Nakamura, Katsumasa
    Abe, Koichiro
    Hirakawa, Masakazu
    Shioyama, Yoshiyuki
    Sasaki, Tomonari
    Baba, Shingo
    Isoda, Takuro
    Ohga, Saiji
    Yoshitake, Tadamasa
    Shinoto, Makoto
    Asai, Kaori
    Honda, Hiroshi
    JOURNAL OF RADIATION RESEARCH, 2013, 54 (05) : 890 - 898
  • [27] Reduction in cardiac volume during chemoradiotherapy for patients with esophageal cancer
    Lutkenhaus, Lotte J.
    Kamphuis, Martijn
    van Wieringen, Niek
    Hulshof, Maarten C. C. M.
    Bel, Arjan
    RADIOTHERAPY AND ONCOLOGY, 2013, 109 (02) : 200 - 203
  • [28] Nutritional management during chemotherapy and chemoradiotherapy for advanced esophageal cancer
    Kimura, Yutaka
    Gakuhara, Atsushi
    Fukuda, Shuichi
    Fukuda, Yasunari
    Yoshihara, Terukazu
    Koga, Chikato
    Haraguchi, Naotsugu
    Hida, Jin-ichi
    ESOPHAGUS, 2025,
  • [29] Cardiac volume effects during chemoradiotherapy for esophageal cancer (Regarding Lutkenhaus et al. Reduction in cardiac volume during chemoradiotherapy for patients with esophageal cancer)
    Edmunds, Katie
    Brooks, Corrinne
    Hansen, Vibeke N.
    Harris, Victoria
    Tait, Diana M.
    RADIOTHERAPY AND ONCOLOGY, 2015, 114 (01) : 128 - 129
  • [30] Preoperative chemoradiotherapy for esophageal cancer
    Kelsen, D
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 283 - 285
12345